# Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)

> **NCT05056389** · PHASE1 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Peritoneal Metastases
- Colo-rectal Cancer

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT05056389
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-17
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05056389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05056389, "Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05056389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*